BSEKerala Ayurveda LtdHighNeutral
Announced Mon, 25 May · 19:44 IST

Outcome of Board meeting held on 25th May 2026

Revenue Growth 20pctPat NegativeNegative Operating CashflowEmphasis Of MatterResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹211.40
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.6-8.6-11.6-15.6-17.0-15.8-12.5-13.0-26.1
Up moveDown movePending
AI summary

Kerala Ayurveda Limited reported audited standalone total income of Rs 10,341.97 lakhs for FY2026, up 32.8% from Rs 7,786.05 lakhs in FY2025. However, the company continues to incur losses with standalone loss after tax of Rs 1,496.15 lakhs (vs loss of Rs 1,387.69 lakhs in FY2025). Consolidated total income was Rs 14,535.69 lakhs, up 19% YoY, with consolidated loss after tax of Rs 2,041.47 lakhs. The statutory auditors issued an unmodified (clean) opinion, but drew attention to significant trade receivables due from subsidiaries outstanding for more than 6 months. The company also appointed Mr. Alphonse Scaria as Internal Auditor and M/s SLR & Associates as Cost Auditor for FY 2026-27.

Likely market impact

Despite strong revenue growth of ~33% on standalone basis, the company remains loss-making with negative operating cash flow of Rs 2,505.15 lakhs, indicating serious cash burn concerns. The Emphasis of Matter on subsidiary receivables adds to investor caution.